Evidence map›Paper›PMID 30110338›Full record

ArticlePloS one2018

The binding of Chp2's chromodomain to methylated H3K9 is essential for Chp2's role in heterochromatin assembly in fission yeast.

Vladimir Maksimov, Eriko Oya, Mayo Tanaka, Takayuki Kawaguchi, Aki Hachisuka, Karl Ekwall, Pernilla Bjerling, Jun-Ichi Nakayama

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Characterization of the Swi6/HP1 binding motif in its partner protein reveals the basis for the functional divergence of the HP1 family proteins in fission yeast.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  3. Article
  4. Article
  5. Establishment of heterochromatin in domain-size-dependent bursts.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Vladimir MaksimovDepartment of Medical Biochemistry and Microbiology (IMBIM), Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Eriko OyaDepartment of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden.
Mayo TanakaDivision of Chromatin Regulation, National Institute for Basic Biology, Okazaki, Japan.
Takayuki KawaguchiDivision of Chromatin Regulation, National Institute for Basic Biology, Okazaki, Japan.
Aki HachisukaDivision of Chromatin Regulation, National Institute for Basic Biology, Okazaki, Japan.
Karl EkwallDepartment of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden.
Pernilla BjerlingDepartment of Medical Biochemistry and Microbiology (IMBIM), Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Jun-Ichi NakayamaDivision of Chromatin Regulation, National Institute for Basic Biology, Okazaki, Japan.ORCID 0000-0002-5597-8239
National Institute for Basic Biology · JPKarolinska Institutet · SEUppsala University · SEUniversity of Fukui · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The binding of heterochromatin protein 1 (HP1) to lysine 9-methylated histone H3 (H3K9me) is an essential step in heterochromatin assembly. Chp2, an HP1-family protein in the fission yeast Schizosaccharomyces pombe, is required for heterochromatic silencing. Chp2 recruits SHREC, a multifunctional protein complex containing the nucleosome remodeler Mit1 and the histone deacetylase Clr3. Although the targeting of SHREC to chromatin is thought to occur via two distinct modules regulated by the SHREC components Chp2 and Clr2, it is not clear how Chp2's chromatin binding regulates SHREC function. Here, we show that H3K9me binding by Chp2's chromodomain (CD) is essential for Chp2's silencing function and for SHREC's targeting to chromatin. Cells expressing a Chp2 mutant with defective H3K9me binding (Chp2-W199A) have a silencing defect, with a phenotype similar to that of chp2-null cells. Genetic analysis using a synthetic silencing system revealed that a Chp2 mutant and SHREC-component mutants had similar phenotypes, suggesting that Chp2's function also affects SHREC's chromatin binding. Size-exclusion chromatography of native protein complexes showed that Chp2-CD's binding of H3K9me3 ensures Clr3's chromatin binding, and suggested that SHREC's chromatin binding is mediated by separable functional modules. Interestingly, we found that the stability of the Chp2 protein depended on the Clr3 protein's histone deacetylase activity. Our findings demonstrate that Chp2's H3K9me binding is critical for SHREC function and that the two modules within the SHREC complex are interdependent.

Indexed as

Cell Cycle ProteinsEscherichia coliHeterochromatinHistonesProtein BindingProtein StabilityRecombinant ProteinsRepressor ProteinsSchizosaccharomycesSchizosaccharomyces pombe ProteinsCell Cycle ProteinsCHP2 protein, S pombeClr3 protein, S pombeHeterochromatinHistonesRecombinant ProteinsRepressor ProteinsSchizosaccharomyces pombe Proteins

Identifiers

PMID30110338
PMCPMC6093649
OpenAlexW2885026227

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.